Ifa Systems FCF Conversion
FCF Conversion Rate (FCF/EBITDA) of Ifa Systems (IS8.HM) as of Aug 5, 2026.
Get this data via API
Financial Data API
FCF Conversion
0.00
Last updated:
FCF Conversion Rate (FCF/EBITDA) of Ifa Systems is 2026 0.00 . FCF Conversion Rate (FCF/EBITDA) of Ifa Systems was 2025 0.00 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API
Ifa Systems Stock analysis
What does Ifa Systems do? Ifa Systems AG is an international company in the field of medical laboratory information systems. It was founded in 1983 in Switzerland and now has its headquarters in Berlin.
The business model of Ifa Systems is based on the development and marketing of software systems that support the process of laboratory diagnostics. This includes optimizing both the technical processes in the analysis laboratories and the management and transmission of data.
The company is divided into three divisions: diagnostic systems, data management, and services. Each of these divisions offers various products and solutions that can be customized individually.
In the field of diagnostic systems, Ifa Systems offers various software solutions that facilitate the analysis of samples and the evaluation of results. This includes instrument management systems, laboratory model solutions, barcode readers, and matching analysis software.
The data management division includes various solutions that help manage data efficiently and securely. For example, Ifa Systems offers systems for archiving patient data, a patient record with privacy protection, and efficient data transfer between different laboratories.
In addition to these two main divisions, Ifa Systems also offers various services tailored to the individual needs of its customers. For example, the range includes training, service offerings, and support in problem-solving.
With years of experience in the development and marketing of laboratory systems, Ifa Systems has established itself as a reliable partner in the medical industry. The company works closely with other providers in the industry and is able to offer integrated solutions.
Ifa Systems aims to develop intelligent software solutions that help simplify and automate laboratory medicine processes. The company places great emphasis on high quality and security, as well as efficient collaboration with its customers. The company is proud to accompany medicine into the digital future and facilitate the daily work of doctors and other medical professionals. Ifa Systems is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Ifa Systems stock
On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Ifa Systems since 2006 – with annual values, charts, and detailed analysis.
FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.
A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Ifa Systems with sector peers and the industry average to assess whether it is attractive.
To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).
Access this data via the Eulerpool API
Cash Flow — Ifa Systems
Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A
All Key Metrics — Ifa Systems
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth